(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.78%.
Vivani Medical's earnings in 2026 is -$26,313,000.On average, 5 Wall Street analysts forecast VANI's earnings for 2026 to be -$29,442,375, with the lowest VANI earnings forecast at -$29,171,765, and the highest VANI earnings forecast at -$28,414,057. On average, 5 Wall Street analysts forecast VANI's earnings for 2027 to be -$36,189,586, with the lowest VANI earnings forecast at -$47,735,616, and the highest VANI earnings forecast at -$25,572,651.
In 2028, VANI is forecast to generate -$36,802,969 in earnings, with the lowest earnings forecast at -$35,359,716 and the highest earnings forecast at -$37,885,410.